Latest Capecitabine Stories
Chemotherapy in addition to the surgery or surgery and radiation improves survival among older women with breast cancer, U.S. researchers said. Corresponding author Dr.
Indian Oncologists Are Starting to Embrace Use of Targeted Agents Despite Their High Cost, According to a Report from Decision Resources WALTHAM, Mass., April 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Sanofi-Aventis' Eloxatin, Indian brand/generics (oxaliplatin) and Roche/Chugai's Xeloda, Indian brand/generics (capecitabine) will dominate the Indian colorectal cancer drug market...
Expects to qualify for 180 days of sole marketing exclusivity PITTSBURGH, April 14 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Hoffmann-La Roche Inc.
Modest Increase in Market Share Expected for Western Drug Companies, According to a Report from Decision Resources WALTHAM, Mass., April 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the colorectal cancer drug market in China will more than double by 2012, growing from $118 million in 2007 to $290 million in 2012.
LONDON and PHILADELPHIA, April 1, /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced the submission of two simultaneous regulatory applications to expand the use of TYVERB(R)/TYKERB(R) (lapatinib).
-Growing Body of Data Supports XELOX as Effective Alternative to Standard of Care- NUTLEY, N.J., Jan.
Nonhormonal chemotherapy treatment regimens, including anthracycline-based regimens and taxanes have been shown to improve overall survival in women with metastatic or recurrent inoperable breast cancer over the last 35 years.Researchers at the University of Ioannina School of Medicine in Greece performed a meta-analysis of 128 clinical trials that included 148 comparisons of breast cancer treatment regimens."Our meta-analysis quantifies the progress achieved in the treatment of advanced...
Indian Physicians Start to Incorporate Targeted Therapies to Achieve Better Efficacy and Toxicity Profiles Than Conventional Therapies, According to a Report From Decision Resources WALTHAM, Mass., Dec.
NUTLEY, N.J., Dec. 9 /PRNewswire/ -- Roche announced today that a total of 20 U.S.
By Martin Eatock A new drug called Lapatinib was recently hailed a "big step forward" for women suffering from advanced breast cancer.
- A poem in which the author retracts something said in an earlier poem.